To determine whether adding blood to a cardioplegic solution affects myocardial preservation, a randomized prospective study was carried out in 60 patients undergoing coronary revascularization to compare the effects of crystalloid potassium cardioplegics (group C) and potassium cardioplegic solutions to which blood has been added ( 973-982, 1984. ALTHOUGH blood-containing cardioplegic solutions have been shown to provide adequate myocardial protection during periods of aortic occlusion,'-' their use in preference to blood-free crystalloid solutions is still controversial. The inclusion of blood in cardioplegic solutions was devised as a means to enhance their myocardial protective characteristics, mainly through increased oxygen-carrying capacity. However, the value of blood as a means of delivery of oxygen to the myocardium has been questioned.9-'' The benefit of blood as a constituent of the cardioplegic solution may vary depending on the temperature and method of administration.3' 10 To explore whether addition of blood to a cardioplegic solution could affect myocardial preservation, a randomized prospective study was conducted to compare the effects of blood-free crystalloid and blood-containing cardioplegic solutions on markers of myocardial metabolism, myocardial damage,
MethodsSixty patients scheduled for elective coronary artery revascularization were studied in a protocol approved by the institutional review board of the University of Alabama in Birmingham.They were assigned to receive either a blood-containing (group B, n = 31) or a clear crystalloid (